• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

SARS-CoV-2 排毒持续时间:一项基于人群的加拿大研究。

Duration of SARS-CoV-2 shedding: A population-based, Canadian study.

机构信息

Department of Family Medicine, Queen's University, Kingston, Ontario, Canada.

Public Health Sciences, Queen's University, Kingston, Ontario, Canada.

出版信息

PLoS One. 2021 Jun 17;16(6):e0252217. doi: 10.1371/journal.pone.0252217. eCollection 2021.

DOI:10.1371/journal.pone.0252217
PMID:34138906
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC8211234/
Abstract

INTRODUCTION

There is an evidence gap regarding the duration of SARS-CoV-2 shedding and of its variability across different care settings and by age, sex, income, and co-morbidities. Such evidence is part of understanding of infectivity and reinfection. We examine direct measures of viral shedding using a linked population-based health administrative dataset.

METHODS

Laboratory and sociodemographic databases for Ontario, Canada were linked to identify those testing positive (RT-PCR) between Jan. 15 and April 30, 2020 who underwent subsequent testing by May 31, 2020. To maximise use of available data, we computed two shedding duration estimates defined as the time between initial positive and most recent positive (documented shedding) or second of two negative tests (documented resolution). We also report multivariable results using quantile regression to examine subgroup differences.

RESULTS

In Ontario, of the 16,595 who tested positive before April 30, 2020, 6604 had sufficient subsequent testing to allow shedding duration calculation. Documented shedding median duration calculated in 4,889 (29% of 16,595) patients was 19 days (IQR 12-28). Documented resolution median duration calculated in 3,219 (19% of the 16,595) patients was 25 days (IQR 18-34). Long-term care residents had 3-5 day longer shedding durations using both definitions. Shorter documented shedding durations of 2-4 days were observed in those living in higher income neighbourhoods. Shorter documented resolution durations of 2-3 days were observed at the 25th% of the distribution in those aged 20-49. Only 11.5% of those with definitive negative test results reverted to negative status by day 14.

CONCLUSIONS

Viral shedding continued well beyond 14 days among this large subset of a population-based group with COVID-19, and longer still for long-term care residents and those living in less affluent neighborhoods. Our findings do not speak to duration of infectivity but are useful for understanding the expected duration of RT-PCR positivity and for identifying reinfection.

摘要

简介

关于 SARS-CoV-2 的脱落持续时间及其在不同护理环境中的变异性,以及年龄、性别、收入和合并症等方面的证据存在差距。这些证据是了解传染性和再感染的一部分。我们使用基于人群的健康管理数据集来检查病毒脱落的直接测量值。

方法

将加拿大安大略省的实验室和社会人口学数据库进行链接,以确定在 2020 年 1 月 15 日至 4 月 30 日期间检测呈阳性(RT-PCR)并在 2020 年 5 月 31 日之前进行后续检测的人。为了最大限度地利用现有数据,我们计算了两个脱落持续时间估计值,定义为初始阳性和最近一次阳性(记录脱落)之间的时间,或两次阴性测试中的第二次(记录分辨率)之间的时间。我们还使用分位数回归报告多变量结果,以检查亚组差异。

结果

在安大略省,在 2020 年 4 月 30 日之前检测呈阳性的 16595 人中,有 6604 人有足够的后续检测来计算脱落持续时间。在 4889 名(16595 名患者的 29%)患者中计算出的记录脱落中位持续时间为 19 天(IQR 12-28)。在 3219 名(16595 名患者的 19%)患者中计算出的记录分辨率中位持续时间为 25 天(IQR 18-34)。使用这两种定义,长期护理居民的脱落持续时间长 3-5 天。在收入较高的社区居住的人观察到 2-4 天的记录脱落持续时间较短。在年龄在 20-49 岁的分布的第 25%处观察到记录分辨率持续时间较短的 2-3 天。只有 11.5%的确诊阴性检测结果在第 14 天前转为阴性。

结论

在 COVID-19 人群的这一大亚组中,病毒脱落持续时间远远超过 14 天,而对于长期护理居民和居住在较贫困社区的人来说,脱落持续时间更长。我们的研究结果不能说明传染性的持续时间,但对于了解 RT-PCR 阳性的预期持续时间和识别再感染很有用。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/d411/8211234/3b14351eb120/pone.0252217.g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/d411/8211234/3b14351eb120/pone.0252217.g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/d411/8211234/3b14351eb120/pone.0252217.g001.jpg

相似文献

1
Duration of SARS-CoV-2 shedding: A population-based, Canadian study.SARS-CoV-2 排毒持续时间:一项基于人群的加拿大研究。
PLoS One. 2021 Jun 17;16(6):e0252217. doi: 10.1371/journal.pone.0252217. eCollection 2021.
2
Clinical characteristics and potential factors for recurrence of positive SARS-CoV-2 RNA in convalescent patients: a retrospective cohort study.恢复期患者 SARS-CoV-2 RNA 复阳的临床特征及潜在影响因素:一项回顾性队列研究。
Clin Exp Med. 2021 Aug;21(3):361-367. doi: 10.1007/s10238-021-00687-y. Epub 2021 Feb 4.
3
Persistent SARS-CoV-2 RNA Shedding Without Evidence of Infectiousness: A Cohort Study of Individuals With COVID-19.持续的 SARS-CoV-2 RNA 脱落而无传染性证据:一项 COVID-19 患者的队列研究。
J Infect Dis. 2021 Oct 28;224(8):1362-1371. doi: 10.1093/infdis/jiab107.
4
Three COVID-19 cases with a long-term viral shedding period in Tunisia.突尼斯出现三例新冠病毒长期排毒病例。
Pan Afr Med J. 2020 Jul 16;35(Suppl 2):117. doi: 10.11604/pamj.supp.2020.35.2.24950. eCollection 2020.
5
Kinetics of Viral Clearance and Antibody Production Across Age Groups in Children with Severe Acute Respiratory Syndrome Coronavirus 2 Infection.儿童严重急性呼吸综合征冠状病毒 2 感染患者各年龄段病毒清除和抗体产生动力学。
J Pediatr. 2020 Dec;227:31-37.e1. doi: 10.1016/j.jpeds.2020.08.078. Epub 2020 Sep 3.
6
An approach to lifting self-isolation for health care workers with prolonged shedding of SARS-CoV-2 RNA.解除对 SARS-CoV-2 RNA 持续排出的医护人员的自我隔离的方法。
Infection. 2021 Feb;49(1):95-101. doi: 10.1007/s15010-020-01530-4. Epub 2020 Oct 6.
7
Diabetes mellitus is a risk factor for prolonged SARS-CoV-2 viral shedding in lower respiratory tract samples of critically ill patients.糖尿病是危重症患者下呼吸道样本中 SARS-CoV-2 病毒持续脱落的一个风险因素。
Endocrine. 2020 Dec;70(3):454-460. doi: 10.1007/s12020-020-02465-4. Epub 2020 Sep 1.
8
Understanding viral shedding of severe acute respiratory coronavirus virus 2 (SARS-CoV-2): Review of current literature.了解严重急性呼吸综合征冠状病毒 2(SARS-CoV-2)的病毒脱落:对现有文献的综述。
Infect Control Hosp Epidemiol. 2021 Jun;42(6):659-668. doi: 10.1017/ice.2020.1273. Epub 2020 Oct 20.
9
Persistence of SARS-CoV-2 RNA in the nasopharyngeal, blood, urine, and stool samples of patients with COVID-19: a hospital-based longitudinal study.新型冠状病毒肺炎患者鼻咽、血液、尿液和粪便样本中 SARS-CoV-2 RNA 的持续存在:一项基于医院的纵向研究。
Virol J. 2021 Jul 1;18(1):134. doi: 10.1186/s12985-021-01599-9.
10
Prolonged SARS-CoV-2 Viral Shedding in Patients with COVID-19 was Associated with Delayed Initiation of Arbidol Treatment and Consulting Doctor Later: A Retrospective Cohort Study.COVID-19 患者中 SARS-CoV-2 病毒持续排出与阿比多尔治疗开始延迟和就诊时间推迟有关:一项回顾性队列研究。
Curr Med Sci. 2021 Dec;41(6):1096-1104. doi: 10.1007/s11596-021-2434-y. Epub 2021 Sep 13.

引用本文的文献

1
Ivermectin as a Treatment Modality in COVID-19 Patients: A Systematic Review and Meta-Analysis of Up-To-Date RCTs.伊维菌素作为新冠肺炎患者的一种治疗方式:对最新随机对照试验的系统评价和荟萃分析
Indian J Community Med. 2025 Jan-Feb;50(1):9-19. doi: 10.4103/ijcm.ijcm_117_23. Epub 2025 Jan 23.
2
Estimation of shedding time in laboratory-confirmed COVID-19 cases in South Africa: a population-based record linkage study, March-December 2020.南非基于人群的病例关联研究估算实验室确诊的 2019 冠状病毒病病例的脱落时间:2020 年 3 月至 12 月。
Pan Afr Med J. 2023 Sep 15;46:24. doi: 10.11604/pamj.2023.46.24.41047. eCollection 2023.
3

本文引用的文献

1
Early Viral Clearance and Antibody Kinetics of COVID-19 Among Asymptomatic Carriers.无症状携带者中 COVID-19 的早期病毒清除及抗体动力学
Front Med (Lausanne). 2021 Mar 15;8:595773. doi: 10.3389/fmed.2021.595773. eCollection 2021.
2
Long-term SARS-CoV-2 RNA shedding and its temporal association to IgG seropositivity.新型冠状病毒长期RNA脱落及其与IgG血清阳性的时间关联。
Cell Death Discov. 2020 Dec 2;6(1):138. doi: 10.1038/s41420-020-00375-y.
3
SARS-CoV-2 viral load is associated with increased disease severity and mortality.
Acute to post-acute COVID-19 thromboinflammation persistence: Mechanisms and potential consequences.
新冠病毒感染从急性期到急性后期血栓炎症的持续存在:机制与潜在后果
Curr Res Immunol. 2023;4:100058. doi: 10.1016/j.crimmu.2023.100058. Epub 2023 Apr 10.
4
Immunocompromised Patients with Protracted COVID-19: a Review of "Long Persisters".患有持续性新冠病毒感染的免疫功能低下患者:“长期感染者”综述
Curr Transplant Rep. 2022;9(4):209-218. doi: 10.1007/s40472-022-00385-y. Epub 2022 Nov 12.
5
The Correlation Between Triglyceride-Glucose Index and SARS-CoV-2 RNA Re-Positive in Discharged COVID-19 Patients.新冠康复患者甘油三酯-葡萄糖指数与新型冠状病毒核糖核酸复阳的相关性
Infect Drug Resist. 2022 Jul 17;15:3815-3828. doi: 10.2147/IDR.S368568. eCollection 2022.
6
The IL-1β, IL-6, and TNF cytokine triad is associated with post-acute sequelae of COVID-19.白细胞介素-1β、白细胞介素-6 和肿瘤坏死因子细胞因子三联体与 COVID-19 的急性后期后遗症有关。
Cell Rep Med. 2022 Jun 21;3(6):100663. doi: 10.1016/j.xcrm.2022.100663.
7
Homologous COVID-19 BNT162b2 mRNA Vaccination at a German Tertiary Care University Hospital: A Survey-Based Analysis of Reactogenicity, Safety, and Inability to Work among Healthcare Workers.德国一家三级护理大学医院的同源 COVID-19 BNT162b2 mRNA 疫苗接种:一项基于调查的医护人员反应原性、安全性及工作能力丧失情况分析
Vaccines (Basel). 2022 Apr 20;10(5):650. doi: 10.3390/vaccines10050650.
8
Viral Evolution and Immunology of SARS-CoV-2 in a Persistent Infection after Treatment with Rituximab.利妥昔单抗治疗后持续性感染中 SARS-CoV-2 的病毒进化和免疫学特征。
Viruses. 2022 Apr 3;14(4):752. doi: 10.3390/v14040752.
9
SARS-CoV-2 screening strategies for returning international travellers: Evaluation of a rapid antigen test approach.针对返回国际旅行者的 SARS-CoV-2 筛查策略:对快速抗原检测方法的评估。
Int J Infect Dis. 2022 May;118:126-131. doi: 10.1016/j.ijid.2022.02.045. Epub 2022 Mar 2.
SARS-CoV-2 病毒载量与疾病严重程度和死亡率的增加有关。
Nat Commun. 2020 Oct 30;11(1):5493. doi: 10.1038/s41467-020-19057-5.
4
Duration of Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) Infectivity: When Is It Safe to Discontinue Isolation?严重急性呼吸综合征冠状病毒 2 (SARS-CoV-2)感染持续时间:何时可以安全解除隔离?
Clin Infect Dis. 2021 Apr 26;72(8):1467-1474. doi: 10.1093/cid/ciaa1249.
5
Sex differences in immune responses that underlie COVID-19 disease outcomes.COVID-19 疾病结局相关的免疫反应中的性别差异。
Nature. 2020 Dec;588(7837):315-320. doi: 10.1038/s41586-020-2700-3. Epub 2020 Aug 26.
6
Comparative study on virus shedding patterns in nasopharyngeal and fecal specimens of COVID-19 patients.新型冠状病毒肺炎患者鼻咽和粪便标本病毒脱落模式的比较研究
Sci China Life Sci. 2021 Mar;64(3):486-488. doi: 10.1007/s11427-020-1783-9. Epub 2020 Aug 5.
7
Prolonged persistence of SARS-CoV-2 in the upper respiratory tract of asymptomatic infected individuals.无症状感染者上呼吸道中 SARS-CoV-2 的持续存在时间较长。
QJM. 2020 Aug 1;113(8):556-560. doi: 10.1093/qjmed/hcaa212.
8
Duration of viral shedding in asymptomatic or mild cases of novel coronavirus disease 2019 (COVID-19) from a cruise ship: A single-hospital experience in Tokyo, Japan.无症状或轻症新型冠状病毒病 2019(COVID-19)病例在游轮上的病毒脱落持续时间:日本东京的一家医院的单中心经验。
Int J Infect Dis. 2020 Aug;97:293-295. doi: 10.1016/j.ijid.2020.06.020. Epub 2020 Jun 12.
9
Persistent detection of SARS-CoV-2 RNA in patients and healthcare workers with COVID-19.在 COVID-19 患者和医护人员中持续检测到 SARS-CoV-2 RNA。
J Clin Virol. 2020 Aug;129:104477. doi: 10.1016/j.jcv.2020.104477. Epub 2020 May 30.
10
Predicting Infectious Severe Acute Respiratory Syndrome Coronavirus 2 From Diagnostic Samples.从诊断样本中预测传染性严重急性呼吸综合征冠状病毒 2。
Clin Infect Dis. 2020 Dec 17;71(10):2663-2666. doi: 10.1093/cid/ciaa638.